VST BIO Corp has raised $60.8M in total funding. The most recent round was Series A.
VST BIO Corp is headquartered in San Diego, CA.
San Diego biologics company led by CEO Krisztina Zsebo, PhD, developing vascular biologic therapies for ischemic stroke and acute cardiovascular disease.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 27, 2026.